Orient Europharma Co (ROCO:4120) Institutional Ownership: 0.25% (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4120 Orient Europharma Co Ltd ROCO:4120
61 GF Score
Price NT$45.70
GF Value NT$47.36
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Orient Europharma Co Institutional Ownership?

Orient Europharma Co ROCO:4120 -3.38% 61 Institutional Ownership is 0.25% as of Sep. 04, 2026. GuruFocus rates ROCO:4120 with a GF Score™ of 61/100 and a GF Value™ of NT$47.36 (Fairly Valued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Orient Europharma Co's institutional ownership is 0.25%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Orient Europharma Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Orient Europharma Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Orient Europharma Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Orient Europharma Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orient Europharma Co Institutional Ownership Chart

Orient Europharma Co Historical Data

The historical data trend for Orient Europharma Co can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.26 0.26 0.25
ROCO:4120
61GF Score
Orient Europharma Co Ltd ROCO:4120
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orient Europharma Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.25% mean?
Orient Europharma Co (ROCO:4120) has a Institutional Ownership of 0.25% as of Sep. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Orient Europharma Co and its competitors.
Is Orient Europharma Co's Institutional Ownership too high?
Orient Europharma Co's current Institutional Ownership is 0.25%. Overall, Orient Europharma Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Orient Europharma Co's Institutional Ownership compare to ZTS?
Orient Europharma Co's Institutional Ownership of 0.25% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Orient Europharma Co and its competitors. Orient Europharma Co's current Institutional Ownership is 0.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orient Europharma Co stock overvalued right now?
Based on GuruFocus' analysis, Orient Europharma Co (ROCO:4120) is currently considered Fairly Valued. The stock's GF Value™ is NT$47.36, compared to a current price of NT$45.70 — trading 3.5% below its estimated fair value. The current Institutional Ownership is 0.25%. Orient Europharma Co's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Orient Europharma Co (ROCO:4120), the current Institutional Ownership is 0.25% as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orient Europharma Co (ROCO:4120) Overvalued in 2026?

Based on GuruFocus' analysis, Orient Europharma Co stock appears to be undervalued. The current stock price of NT$45.70 is trading 3.5% below its estimated GF Value™ of NT$47.36. GuruFocus considers Orient Europharma Co to be Fairly Valued.

Key valuation signals for ROCO:4120:

  • Institutional Ownership: 0.25%
  • GF Value™: NT$47.36 vs. price of NT$45.70 (3.5% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4120 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orient Europharma Co Business Description

Address 13th Floor, No. 128, Chengde Road, Section 6, Beitou District, Taipei, TWN, 112052
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements. The company's segments include: Western Pharma BU which includes manufacture and sale of pharmaceutical and cosmetic products; and Nutricare BU includes sale of various nutrition supplements and consumable healthcare products. It derives maximum revenue from Western Pharma BU segment. Geographically, it operates in Taiwan, China, and Southeast Asia.
61GF Score

Get the complete analysis for ROCO:4120

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.70
Price
NT$47.36
GF Value